Vasomotor Symptoms of Menopause Treatment Market Report

Global and Region Vasomotor Symptoms of Menopause Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：166
  • REPORT CODE：GMM959114
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Vasomotor Symptoms of Menopause Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Vasomotor Symptoms of Menopause Treatmentmarket, defines the market attractiveness level of Vasomotor Symptoms of Menopause Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Vasomotor Symptoms of Menopause Treatment industry, describes the types of Vasomotor Symptoms of Menopause Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vasomotor Symptoms of Menopause Treatment market and the development prospects and opportunities of Vasomotor Symptoms of Menopause Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vasomotor Symptoms of Menopause Treatment market in Chapter 13.

    By Player:

    • EndoCeutics, Inc

    • TherapeuticsMD, Inc

    • Pivot Pharmaceuticals Inc

    • Amgen Inc

    • Pherin Pharmaceuticals, Inc

    • MenoGeniX, Inc

    • Mithra Pharmaceuticals SA

    • Radius Health, Inc

    • Euroscreen SA

    By Type:

    • Estetrol

    • Fezolinetant

    • FP-101

    • HBN-2

    • Others

    By End-User:

    • Hospital

    • Homecare

    • Clinic

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Vasomotor Symptoms of Menopause Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Vasomotor Symptoms of Menopause Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Vasomotor Symptoms of Menopause Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Vasomotor Symptoms of Menopause Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Vasomotor Symptoms of Menopause Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.2 United States Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.3 Europe Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.4 China Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.5 Japan Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.6 India Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    • 7.7 South Korea Vasomotor Symptoms of Menopause Treatment Consumption (2017-2022)

    8 Region and Country-wise Vasomotor Symptoms of Menopause Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.4 China Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.6 India Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Vasomotor Symptoms of Menopause Treatment Consumption Forecast (2022-2028)

    9 Global Vasomotor Symptoms of Menopause Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Estetrol Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Fezolinetant Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global FP-101 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global HBN-2 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)

    10 Global Vasomotor Symptoms of Menopause Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Estetrol Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Fezolinetant Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global FP-101 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global HBN-2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    11 Global Vasomotor Symptoms of Menopause Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Vasomotor Symptoms of Menopause Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Vasomotor Symptoms of Menopause Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Vasomotor Symptoms of Menopause Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Vasomotor Symptoms of Menopause Treatment Market Competitive Analysis

    • 14.1 EndoCeutics, Inc

      • 14.1.1 EndoCeutics, Inc Company Details

      • 14.1.2 EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.2 TherapeuticsMD, Inc

      • 14.2.1 TherapeuticsMD, Inc Company Details

      • 14.2.2 TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.3 Pivot Pharmaceuticals Inc

      • 14.3.1 Pivot Pharmaceuticals Inc Company Details

      • 14.3.2 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.4 Amgen Inc

      • 14.4.1 Amgen Inc Company Details

      • 14.4.2 Amgen Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.5 Pherin Pharmaceuticals, Inc

      • 14.5.1 Pherin Pharmaceuticals, Inc Company Details

      • 14.5.2 Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.6 MenoGeniX, Inc

      • 14.6.1 MenoGeniX, Inc Company Details

      • 14.6.2 MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.7 Mithra Pharmaceuticals SA

      • 14.7.1 Mithra Pharmaceuticals SA Company Details

      • 14.7.2 Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.8 Radius Health, Inc

      • 14.8.1 Radius Health, Inc Company Details

      • 14.8.2 Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • 14.9 Euroscreen SA

      • 14.9.1 Euroscreen SA Company Details

      • 14.9.2 Euroscreen SA Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Euroscreen SA Vasomotor Symptoms of Menopause Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Vasomotor Symptoms of Menopause Treatment

    • Figure Vasomotor Symptoms of Menopause Treatment Picture

    • Table Global Vasomotor Symptoms of Menopause Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Vasomotor Symptoms of Menopause Treatment Consumption by Country (2017-2022)

    • Figure United States Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vasomotor Symptoms of Menopause Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vasomotor Symptoms of Menopause Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Estetrol Consumption and Growth Rate (2017-2022)

    • Figure Global Fezolinetant Consumption and Growth Rate (2017-2022)

    • Figure Global FP-101 Consumption and Growth Rate (2017-2022)

    • Figure Global HBN-2 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Estetrol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fezolinetant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global FP-101 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HBN-2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table EndoCeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table TherapeuticsMD, Inc (Foundation Year, Company Profile and etc.)

    • Table TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Pivot Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Pherin Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table MenoGeniX, Inc (Foundation Year, Company Profile and etc.)

    • Table MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Mithra Pharmaceuticals SA (Foundation Year, Company Profile and etc.)

    • Table Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Radius Health, Inc (Foundation Year, Company Profile and etc.)

    • Table Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Product and Service

    • Table Euroscreen SA (Foundation Year, Company Profile and etc.)

    • Table Euroscreen SA Vasomotor Symptoms of Menopause Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Euroscreen SA Vasomotor Symptoms of Menopause Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US